Lung Cancer: Felipe's Patient Story

Patient Info: Felipe, male, 60s

Felipe has moved beyond surgery and continues regular surveillance scans while rebuilding his health and life after treatment.

GO2 FoundationRead more →

Katie's Marathon: 25% Less Lung and 25% More Heart

Patient Info: Katie, Female, Under 40

After a lobectomy for neuroendocrine lung cancer diagnosed during pregnancy, Katie was described as a lung-cancer survivor and later completed the Paris Marathon.

Lung Cancer: Randi's Patient Story

Patient Info: Randi Young, Female, 70+

At age 70, Randi was living with lung cancer after lobectomy and while taking targeted therapy, and she continued skiing, jogging, and solo backpacking while completing an 11-mile event.

Stage IV EGFR Non-Small Cell Lung Cancer: Valerie's Patient Story

Patient Info: Valerie Brown, Female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion

Valerie was stable for more than 20 months on targeted therapy for Stage IV EGFR exon 19-deleted lung adenocarcinoma.

The Pervasive Stigma Associated With Lung Cancer

Patient Info: Anonymized

Biomarkers: EGFR exon 19 deletion

After right upper lobectomy and chemotherapy, the patient continued a daily targeted-therapy tablet for EGFR exon 19-deleted lung adenocarcinoma.

Stage IV ALK Lung Cancer: Frank's Survivor Story

Patient Info: Frank Sierawski, Male | Stage IV

Biomarkers: ALK-positive

Frank was disease-free for more than 7 years while continuing his second ALK-targeted tyrosine kinase inhibitor after lobectomy and brain radiation.

Lung Cancer: Martine's Survivor Story

Patient Info: Martine, Female, 60s

Martine was 66 and retired when she shared her lung cancer story; after chemotherapy, right lung lobectomy, and more chemotherapy, she was in remission and rebuilding an active life.

Stage IV HER2-Positive Breast Cancer: Leftfootforward's Survivor Story

Patient Info: Leftfootforward, Female, Under 40 | Stage IV

Biomarkers: HER2-positive

Metastatic Site: Brain | Liver

Leftfootforward was diagnosed with Stage IIB HER2-positive breast cancer in 2010 and metastatic brain/liver disease in 2012; after systemic therapy, Gamma Knife, craniotomy for necrotic tissue, partial liver lobectomy, and resumed Herceptin, her latest scans showed no evidence of disease.

BreastCancer.org (ES)Read more →

Lung Cancer: Julie's Survivor Story

Patient Info: Julie, Female, 70+

Julie had early-stage localized lung cancer without metastases, underwent right upper-lobe lobectomy and 6 chemotherapy treatments, and was told in October 2017 that she was in complete remission.

Lung Cancer: Carole's Survivor Story

Patient Info: Carole, Female, 70+

Carole’s mother was treated for lung cancer with lobectomy and chemotherapy and was later described as being in remission, active, exercising, and traveling.

Stage I EGFR Lung Adenocarcinoma: Julie's Patient Story

Patient Info: Julie, Female, 40s | Stage I

Biomarkers: EGFR exon 19 deletion

Ongoing care after Stage IB EGFR exon 19 lung adenocarcinoma treated with lower left lobectomy and Tagrisso/osimertinib, with CT and MRI surveillance; no recurrence/NED statement is explicitly provided.

Lung Cancer Research FoundationRead more →

Stage I Lung Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rosato Perea, Female | Stage I

Cancer-free after February 2022 lower-right-lobe lobectomy for Stage I lung cancer, with no chemotherapy, radiation, or clinical trial treatment needed; returned to running and completed endurance events.

Lung Cancer Research FoundationRead more →

Lung cancer surgery complicated by a delayed tracheal tear

Patient Info: Anonymized, male, 70+

He died 37 days after lung-cancer surgery following a prolonged postoperative course complicated by bleeding, a tracheal tear and progressive respiratory and hemodynamic deterioration.

PubMed CentralRead more →

Delayed adrenal insufficiency after lung cancer immunotherapy

Patient Info: Anonymized, male, 60s | Stage II

Imaging and bronchoscopy in November 2024 showed no lung-cancer recurrence or metastasis. By June 2026, he had not experienced another adrenal crisis while continuing hormone replacement.

PubMed CentralRead more →

More than 5 years living with metastatic lung adenocarcinoma after stepwise molecular testing

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2 amplification, EGFR L858R mutation, PD-L1 <1%

Metastatic Site: brain, lung

As of April 2026, she remained on gefitinib with no active tumor lesions after complete regression of lung metastases, more than 5 years (66 months) after her original diagnosis.

PubMed CentralRead more →

Lung adenocarcinoma that spread to the thyroid 9 years later

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: thyroid

After the thyroid metastasis was removed, she started systemic chemotherapy and remained under oncology management.

PubMed CentralRead more →

Stage II KRAS Lung Adenocarcinoma: Roy's Survivor Story

Patient Info: Roy, Male, 50s | Stage II

Biomarkers: KRAS

As of May 2026, Roy described being cancer-free/in remission, back to flying professionally, and strong enough to complete his 5th marathon at the Boston Marathon.

The Patient StoryRead more →

Three separate primary cancers: lung squamous carcinoma, gastric adenocarcinoma, and hepatocellular carcinoma

Patient Info: Anonymized, Male, 60s

Biomarkers: Multiple primaries: lung squamous markers CK5/6 and P40; gastric cancer HER2 negative; liver cancer markers hepatocyte/GPC3/HSP70/CD34.

As of May 2026, all 3 primary cancers were controlled: lung cancer had no recurrence after surgery, gastric cancer remained in sustained remission on sintilimab maintenance, and hepatocellular carcinoma was controlled after ablation; ECOG performance status was 1.

PubMed CentralRead more →

No recurrence 7 months after surgery for a rare lung epithelial-myoepithelial cancer

Patient Info: Anonymized, Male, 60s | Stage I

At 7-month follow-up, there was no sign of recurrence after surgery.

PubMed CentralRead more →

Early-stage synchronous lung cancers: tumor-free after lobectomy with delayed respiratory and neuropsychiatric complications

Patient Info: Anonymized, Male, 60s

Biomarkers: No molecular biomarkers reported

More than 3 years after thoracoscopic right middle and lower lobectomy, he remained tumor-free, although he had delayed cardiopulmonary, weight-loss, and neuropsychiatric complications after surgery.

PubMed CentralRead more →

No recurrence 2 years after surgery for Stage II lung adenocarcinoma

Patient Info: Anonymized, Male, 50s | Stage II

At 2-year follow-up, he remained well with no local recurrence or distant metastasis.

PubMed CentralRead more →

Stage II Lung Cancer: Michelle's Patient Story

Patient Info: Michelle, Female | Stage II

Receiving ongoing adjuvant treatment after lung cancer first thought to be Stage I was upgraded to Stage IIB because 3 of 18 lymph nodes were positive.

The Patient StoryRead more →

Stage III lung cancer treatment complicated by immune-related lung inflammation

Patient Info: Anonymized, Male, 60s | Stage III

Biomarkers: EGFR-negative; ALK-negative; ROS1-negative

Mediastinal lymph nodes later enlarged despite additional systemic treatment, prompting radiation and further therapy.

PubMed CentralRead more →

Stage II EGFR Non-Small Cell Lung Cancer: Daniel's Patient Story

Patient Info: Daniel West, Male, 50s | Stage II

Biomarkers: EGFR positive

As of April 2026, Daniel had shown no evidence of active disease for more than 2 years, while remaining on daily osimertinib through June 2026 and receiving checkups and scans every 3 months for stable monitored lung nodules.

MD AndersonRead more →